The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Shared Mechanisms between Cardiovascular Disease and NAFLD
Semin Liver Dis. 2022 Nov;42(4):455-464. doi: 10.1055/a-1930-6658.Epub 2022 Aug 25.
1NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, San Diego, California.
2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
3Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore.
4Gene Expression Laboratory, Salk Institute for Biological Studies, San Diego, California.
5Division of Endocrinology and Metabolism, Department of Medicine, University California San Diego, San Diego, California.
6Department of Cellular and Molecular Medicine, University of California San Diego, San Diego, California.
7Department of Medicine, University of California San Diego, San Diego, California.
8Division of Epidemiology, Department of Family Medicine and Public Health, University of California at San Diego, San Diego, California.
Abstract
The burden of nonalcoholic fatty liver disease (NAFLD) is rising globally. Cardiovascular disease is the leading cause of death in patients with NAFLD. Nearly half of individuals with NAFLD have coronary heart disease, and more than a third have carotid artery atherosclerosis. Individuals with NAFLD are at a substantially higher risk of fatal and nonfatal cardiovascular events. NAFLD and cardiovascular disease share multiple common disease mechanisms, such as systemic inflammation, insulin resistance, genetic risk variants, and gut microbial dysbiosis. In this review, we discuss the epidemiology of cardiovascular disease in NAFLD, and highlight common risk factors. In addition, we examine recent advances evaluating the shared disease mechanisms between NAFLD and cardiovascular disease. In conclusion, multidisciplinary collaborations are required to further our understanding of the complex relationship between NAFLD and cardiovascular disease and potentially identify therapeutic targets.